Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
62 studies found for:    Open Studies | "Eosinophilia"
Show Display Options
Rank Status Study
21 Recruiting A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Condition: Familial Hypereosinophilia
22 Unknown  Effect of Hypertonic Solutions on Allergic Rhinitis Patients
Condition: Allergic Rhinitis
23 Not yet recruiting Trial of Ketotifen in Children and Adolescents
Condition: Functional Dyspepsia
Interventions: Drug: Ketotifen;   Drug: Placebo
24 Not yet recruiting EoE Food Desensitization
Condition: Eosinophilic Esophagitis
Intervention: Dietary Supplement: Oral food desensitization
25 Not yet recruiting Safety and Efficacy of Three Doses of Oral Fluticasone Propionate in Adults With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: EMS Fluticasone 1;   Drug: EMS Fluticasone 2;   Drug: EMS Fluticasone 3;   Other: EMS Placebo Fluticasone
26 Not yet recruiting Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Interventions: Drug: Mepolizumab 300 mg;   Drug: Placebo matching mepolizumab;   Drug: Active OCS capsules (5 mg prednisolone or prednisone);   Drug: Placebo matching OCS capsules
27 Recruiting SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis (EoE)
Interventions: Other: elimination diet therapy;   Drug: Flovent
28 Recruiting Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Intervention: Other: Observation Period
29 Recruiting Myeloproliferative Neoplasms (MPNs) Patient Registry
Conditions: Primary Myelofibrosis;   Polycythemia Vera;   Essential Thrombocythemia;   Mastocytosis;   Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative;   Leukemia, Myelomonocytic, Juvenile;   Chronic Eosinophilic Leukemia-not Otherwise Specified;   Myelodysplastic-Myeloproliferative Diseases;   Neoplasms;   Leukemia, Myelomonocytic, Chronic
Intervention: Other: Observational
30 Recruiting An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: Oral Budesonide Suspension (OBS);   Drug: Placebo
31 Recruiting Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids
Conditions: Eosinophilic Esophagitis;   Eosinophilic Gastrointestinal Disorders (EGIDs),
Interventions: Other: elimination diet therapy;   Drug: Flovent (fluticasone propionate)
32 Recruiting A Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: OBS;   Drug: Placebo
33 Recruiting Cytosponge and Dietary Therapy in EoE
Condition: Eosinophilic Esophagitis
Interventions: Device: Cytosponge;   Other: Diet;   Other: Phone call;   Other: EEsAI Pro
34 Recruiting Milk Patch for Eosinophilic Esophagitis
Conditions: Eosinophilic Esophagitis;   Milk Allergy
Interventions: Drug: Viaskin Milk 500 mcg;   Drug: Viaskin Placebo
35 Recruiting a4b7 Integrin in Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Intervention: Other: Eosinophil isolation and characterization.
36 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
37 Not yet recruiting Maintenance of Remission With Budesonide Effervescent Tablets vs. Placebo in Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Budesonide effervescent 0.5mg tablet twice daily;   Drug: Budesonide effervescent 1mg tablet twice daily;   Drug: Placebo effervescent tablet twice daily
38 Recruiting Fibrostenotic Eosinophilic Esophagitis: Assessment Tools
Condition: Eosinophilic Esophagitis
39 Recruiting Budesonide Effervescent Tablet vs. Placebo in Active Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Budesonide effervescent 1mg tablet twice daily;   Drug: Placebo effervescent tablet twice daily
40 Recruiting Study of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis (EoE)
Condition: Eosinophilic Esophagitis
Interventions: Drug: Dupilumab;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years